March 6, 2026
1 min read

Lonza hands off capsule business to investment firm Lone Star in $3B deal

Under the deal with Lone Star Funds, Lonza maintains a 40% stake in its capsules and health ingredients business while receiving 1.7 billion Swiss francs ($2.2 billion) upfront.

Leave a Reply

Your email address will not be published.

Previous Story

Some Patients Keep Weight off With Fewer GLP-1 Injections, Study Finds MedNews

Next Story

How Important Is Protein in the Morning?

Previous Story

Some Patients Keep Weight off With Fewer GLP-1 Injections, Study Finds MedNews

Next Story

How Important Is Protein in the Morning?

Latest from Blog

Go toTop